Clofarabine and ascites 
Clofarabine and ascites Patient Reports February 11, 2012
Clofarabine Side Effects Report #5775068-0
Clofarabine side effect was reported by a Physician from UNITED STATES on June 05, 2008. Female patient, 68 years of age, weighting 143.7 lb, was diagnosed with stem cell transplant and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: abdominal pain
, ascites, pleural effusion, portal vein flow decreased, weight increased. Clofarabine dosage: 30 MG/M2, QD, INTRAVENOUS. During the same period patient was treated with BUSULFAN, URSODIOL, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Clofarabine Side Effects Report #5796289-7
Clofarabine side effect was reported by a Physician from UNITED STATES on June 18, 2008. Female patient, 68 years of age, weighting 143.7 lb, was diagnosed with stem cell transplant and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: ascites, hepatic atrophy, pleural effusion, portal vein flow decreased, stem cell transplant, weight increased. Clofarabine dosage: 30 MG/M2, QD, INTRAVENOUS. During the same period patient was treated with BUSULFAN, URSODIOL, CYCLOSPORINE. Patient was hospitalized. Patient recovered.
Clofarabine Side Effects Report #5818545-6
Clofarabine side effect was reported by a Physician from UNITED STATES on July 08, 2008. Female patient, 68 years of age, weighting 143.7 lb, was diagnosed with stem cell transplant and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: abdominal pain
, ascites, diarrhoea, nausea , pleural effusion, post procedural discomfort, weight increased. Clofarabine dosage: 30 MG/M2, QD, INTRAVENOUS. During the same period patient was treated with BUSULFAN, URSODIOL, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Clofarabine Side Effects Report #5833151-5
Clofarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on July 22, 2008. Female patient, 68 years of age, weighting 143.7 lb, was diagnosed with stem cell transplant and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, ascites, blood creatinine increased, cholelithiasis, culture stool positive, culture urine positive, diarrhoea, discomfort. Clofarabine dosage: 30 MG/M2, QD, INTRAVENOUS. During the same period patient was treated with BUSULFAN, URSODIOL, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Clofarabine Side Effects Report #5849995-X
Clofarabine side effect was reported by a Physician from UNITED STATES on Aug 07, 2008. Female patient, 68 years of age, weighting 143.7 lb, was diagnosed with stem cell transplant and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: ascites, bacteria stool identified, blood creatinine increased, cholelithiasis, diarrhoea, enterococcal infection, graft versus host disease, haemochromatosis, hepatic fibrosis. Clofarabine dosage: 30 MG/M2, QD, INTRAVENOUS. During the same period patient was treated with BUSULFAN, URSODIOL, CYCLOSPORINE. Patient was hospitalized. Patient recovered.
Clofarabine Side Effects Report #5871147-8
Clofarabine side effect was reported by a Health Professional from UNITED STATES on Aug 22, 2008. Female patient, 68 years of age, weighting 143.7 lb, was diagnosed with stem cell transplant and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: ascites, blood creatinine increased, blood glucose increased, bone marrow transplant
, cholelithiasis, diarrhoea, enterococcal infection, graft versus host disease, haemochromatosis. Clofarabine dosage: 30 MG/M2, QD, INTRAVENOUS. During the same period patient was treated with BUSULFAN, URSODIOL, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Clofarabine Side Effects Report #5909087-8
Clofarabine side effect was reported by a Physician from UNITED STATES on Sept 19, 2008. Female patient, 68 years of age, weighting 143.7 lb, was diagnosed with stem cell transplant and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: ascites, blood creatinine increased, cholelithiasis, culture stool positive, diarrhoea, enterococcal infection, haemochromatosis, haemosiderosis, hepatic fibrosis. Clofarabine dosage: 30 MG/M2, QD, INTRAVENOUS. During the same period patient was treated with BUSULFAN, URSODIOL, CYCLOSPORINE. Patient was hospitalized. Patient recovered.
Clofarabine Side Effects Report #5752364-4
Clofarabine side effect was reported by a Physician from UNITED STATES on May 16, 2008. Female patient, 60 years of age, was diagnosed with stem cell transplant and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: abdominal pain
, acute pulmonary oedema, ascites, blood creatinine increased, cardiac arrest , hypervolaemia, hypotension. Clofarabine dosage: unknown. During the same period patient was treated with CAMPATH, MELPHALAN. Patient was hospitalized. Patient died on 05/16/2008.Clofarabine Side Effects Report #5761977-5
Clofarabine side effect was reported by a Physician from UNITED STATES on May 28, 2008. Female patient, 60 years of age, weighting 239.2 lb, was diagnosed with stem cell transplant and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: abdominal pain
, ascites, aspiration, blood creatinine increased, cardio-respiratory arrest, fluid overload, hallucination, hypervolaemia. Clofarabine dosage: 84 MG, QDX5, INTRAVENOUS. During the same period patient was treated with CAMPATH, MELPHALAN, ZOFRAN, ZOLOFT, INDERAL, METHADONE. Patient was hospitalized. Patient died on 05/16/2008.Clofarabine Side Effects Report #5580117-9
Clofarabine side effect was reported by a Health Professional from UNITED STATES on Dec 27, 2007. Male patient, weighting 183.4 lb, was diagnosed with stem cell transplant and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: ascites, clostridial infection, colitis, dehydration, dyspnoea, gastrointestinal disorder, ischaemia, pseudomembranous colitis. Clofarabine dosage: 88 MG DAILY IV DRIP. During the same period patient was treated with CAMPATH, MELPHALAN. Patient was hospitalized. Patient recovered.
Clofarabine Side Effects Report #5743836-7
Clofarabine side effect was reported by a Health Professional from UNITED STATES on May 19, 2008. Female patient was diagnosed with stem cell transplant and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: abdominal pain
, acute pulmonary oedema, ascites, blood creatinine increased, cardiac arrest , dyspnoea, flatulence, hypervolaemia. Clofarabine dosage: unknown. During the same period patient was treated with CAMPATH, MELPHALAN. Patient died on 05/16/2008.Clofarabine Side Effects Report #5756938-6
Clofarabine side effect was reported by a Health Professional from UNITED STATES on May 22, 2008. Female patient was diagnosed with stem cell transplant and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: ascites, hepatic atrophy, portal vein flow decreased, weight increased. Clofarabine dosage: 30 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with BUSULFAN. Patient was hospitalized. Patient recovered.
Clofarabine Side Effects Report #5764137-7
Clofarabine side effect was reported by a Physician from UNITED STATES on May 23, 2008. Female patient was diagnosed with stem cell transplant and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: ascites, pleural effusion. Clofarabine dosage: 30 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with BUSULFAN. Patient was hospitalized. Patient recovered.
Clofarabine Side Effects Report #5069042-X
Clofarabine side effect was reported by a Health Professional from UNITED STATES on July 17, 2006. Male patient, 62 years of age, was diagnosed with chronic myelomonocytic leukaemia, myelodysplastic syndrome and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: ascites, dialysis
, renal failure. Clofarabine dosage: 78 MG QD X 5 IV. During the same period patient was treated with ALLOPURINOL, CEFEPIME, LEVAQUIN, VANCOMYCIN, AZTREONAM, VORICONAZOLE. Patient recovered.Clofarabine Side Effects Report #5097831-4
Clofarabine side effect was reported by a Physician from UNITED STATES on Aug 22, 2006. Male patient, 62 years of age, was diagnosed with chronic myelomonocytic leukaemia, myelodysplastic syndrome and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: ascites, dialysis
, renal failure. Clofarabine dosage: 78 MG QD X 5 IV. During the same period patient was treated with ALLOPURINOL, CEFEPIME, LEVAQUIN, VANCOMYCIN, AZTREONAM, VORICONAZOLE. Patient recovered.Clofarabine Side Effects Report #5417875-X
Clofarabine side effect was reported by a Physician from SPAIN on July 30, 2007. Male patient, child 11 years of age, weighting 81.57 lb, was diagnosed with adult t-cell lymphoma/leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: agitation, anorexia, anxiety
, ascites, blood calcium increased, blood lactate dehydrogenase increased, blood phosphorus decreased, blood potassium decreased, capillary leak syndrome. Clofarabine dosage: 40 MG/M2 QD IV. During the same period patient was treated with PREDNISONE, MORPHINE, ELITEK, DEXAMETHASONE, FLUCONAZOLE, FAMCICLOVIR, IBRUPROFEN, OMEPRAZOLE. Patient died on 07/21/2007.Clofarabine Side Effects Report #5664302-3
Clofarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 28, 2008. Female patient, 73 years of age, weighting 124.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: abdominal pain
, ascites, atelectasis, atrial fibrillation , cholecystitis, culture positive, depressed level of consciousness, febrile neutropenia, fungus sputum test positive. Clofarabine dosage: 50 MG, QDX5, INTRAVENOUS. During the same period patient was treated with INSULIN, ZYPREXA, MAGNESIUM SULPHATE, CHLORIDE, POTASSIUM CHLORIDE. Patient was hospitalized. Patient died on 03/14/2007.Clofarabine Side Effects Report #6024232-4
Clofarabine side effect was reported by a Physician from UNITED STATES on Dec 17, 2008. Female patient, 68 years of age, weighting 122.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, bacteria stool identified, bacteria urine identified, blood creatinine increased, cholelithiasis, diarrhoea, enterococcal infection, flatulence. Clofarabine dosage: 48.6 MG, QDX5, INTRAVENOUS. During the same period patient was treated with BUSULFAN, URSODIOL, CYCLOSPORINE, TACROLIMUS, MYCOPHENOLATE MOFETIL, ACYCLOVIR, DIPHENHYDRAMINE, HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient recovered.
Clofarabine Side Effects Report #5772219-9
Clofarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2008. Male patient, child 2 years of age, was diagnosed with acute myeloid leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: ascites, blood bilirubin increased, hepatomegaly, orchitis, post procedural infection, pseudomonal sepsis, rash
, venoocclusive disease. Clofarabine dosage: 20 MG/M2, INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient died.Clofarabine Side Effects Report #5091346-5
Clofarabine side effect was reported by a Physician from UNITED STATES on Aug 09, 2006. Female patient, child 6 years of age, weighting 46.96 lb, was diagnosed with acute lymphocytic leukaemia recurrent and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: angiopathy, ascites, bladder disorder, blood amylase increased, blood urine present, colitis, computerised tomogram abnormal, cystitis, ejection fraction decreased. Clofarabine dosage: 17 MG QD X 5; IV. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, MORPHINE, DIPHENHYDRAMINE, ACETAMINOPHEN, REGULAR INSULIN, FAMOTIDINE, NEUPOGEN. Patient was hospitalized. Patient recovered.
Clofarabine Side Effects Report #5097830-2
Clofarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 22, 2006. Female patient, child 6 years of age, weighting 46.96 lb, was diagnosed with acute lymphocytic leukaemia, leukaemia recurrent and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, alpha haemolytic streptococcal infection, ascites, bk virus infection, blood amylase increased, bone marrow failure, colitis, cystitis haemorrhagic. Clofarabine dosage: 17 MG QD X 5 IV. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, MORPHINE, DIPHENHYDRAMINE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.Clofarabine Side Effects Report #5237912-5
Clofarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 30, 2007. Female patient, child 5 years of age, weighting 27.12 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: ascites, cellulitis
, hypoxia, intestinal obstruction, lymphadenopathy, neutropenic colitis, pleural effusion. Clofarabine dosage: 18 MG QD X 5 IV. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.Clofarabine Side Effects Report #5245844-1
Clofarabine side effect was reported by a Health Professional from UNITED STATES on Feb 02, 2007. Female patient, child 5 years of age, weighting 27.12 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: abscess intestinal, ascites, blast cell count increased, cellulitis
, disease progression, disease recurrence, hypoxia, intestinal obstruction, joint range of motion decreased. Clofarabine dosage: 18 MG QD X 5 IV. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient died on 02/09/2007.Clofarabine Side Effects Report #5255319-1
Clofarabine side effect was reported by a Health Professional from UNITED STATES on Feb 16, 2007. Female patient, child 5 years of age, weighting 27.12 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: ascites, bronchial disorder, cellulitis
, disease progression, hypoxia, lymphadenopathy, neutropenic colitis, platelet count decreased, pleural effusion. Clofarabine dosage: 18 MG QD X 5 IV. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient died on 02/09/2007.Clofarabine Side Effects Report #5301468-9
Clofarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 01, 2007. Female patient, child 5 years of age, weighting 27.12 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: abdominal distension, acute leukaemia, arthropathy, ascites, blast cell count increased, cellulitis
, chest x-ray abnormal, disease progression, hypoxia. Clofarabine dosage: 18 MG QD X 5; IV. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient died on 02/09/2007.Clofarabine Side Effects Report #5644405-X
Clofarabine side effect was reported by a Physician from UNITED STATES on Feb 14, 2008. Female patient, child 5 years of age, weighting 27.12 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: abdominal distension, anorectal discomfort, arthropathy, ascites, blast cells present, bronchial disorder, caecitis, cellulitis
, disease progression. Clofarabine dosage: 18 MG, QDX5, INTRAVENOUS; 18MG, QD, INTRAVENOUS, 18 MG, QD, INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient died on 02/09/2007.Clofarabine Side Effects Report #5173528-7
Clofarabine side effect was reported by a Health Professional from UNITED STATES on Dec 04, 2006. Female patient, 26 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, cellulitis gangrenous, erythema, hyperbilirubinaemia, hypotension, neutropenia, pyrexia, skin nodule. Clofarabine dosage: 60 MG QD X 3 IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, AMBISOME, AUGMENTIN, BACTRIM DS, COMPAZINE, CYTARABINE, DEXAMETHASONE, KEPPRA. Patient was hospitalized. Patient recovered.
Clofarabine Side Effects Report #5878582-2
Clofarabine side effect was reported by a Physician from FRANCE on Aug 29, 2008. Male patient, 22 years of age, weighting 110.2 lb, was diagnosed with acute lymphocytic leukaemia, palmar-plantar erythrodysaesthesia syndrome and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: anaemia, aplasia, ascites, enterocolitis, mucosal inflammation, oedematous pancreatitis, palmar-plantar erythrodysaesthesia syndrome, platelet count decreased. Clofarabine dosage: 40 MG/M2, INTRAVENOUS. During the same period patient was treated with CYTARABINE, SULFADIAZINE. Patient recovered.
Clofarabine Side Effects Report #5914545-6
Clofarabine side effect was reported by a Physician from FRANCE on Sept 26, 2008. Male patient, 22 years of age, weighting 110.2 lb, was diagnosed with acute lymphocytic leukaemia, palmar-plantar erythrodysaesthesia syndrome and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: anaemia, aplasia, ascites, asthenia, cellulitis
, dermo-hypodermitis, enterocolitis, febrile bone marrow aplasia, mucosal inflammation. Clofarabine dosage: 40 MG/M2, INTRAVENOUS. During the same period patient was treated with CYTARABINE, SULFADIAZINE. Patient recovered.Clofarabine Side Effects Report #5745897-8
Clofarabine side effect was reported by a Health Professional from UNITED STATES on May 06, 2008. Male patient, 20 years of age, weighting 118.2 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: acute interstitial pneumonitis, acute respiratory distress syndrome, adenovirus infection, alanine aminotransferase increased, anorectal infection bacterial, ascites, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased. Clofarabine dosage: 68 MG, QD, INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, ACETAMINOPHEN, ACYCLOVIR, ALLOPURINOL, CEFEPIME, BENADRYL, DRONABINOL. Patient was hospitalized. Patient recovered.
Clofarabine Side Effects Report #5756608-4
Clofarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on May 16, 2008. Male patient, 20 years of age, weighting 118.2 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: acute interstitial pneumonitis, acute respiratory distress syndrome, adenovirus infection, anorectal infection, ascites, bronchoalveolar lavage abnormal, catheter related infection, cholelithiasis, cholestasis. Clofarabine dosage: 68 MG, QD, INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, ACETAMINOPHEN, ACYCLOVIR, ALLOPURINOL, CEFEPIME, BENADRYL, DRONABINOL. Patient was hospitalized. Patient recovered.
Clofarabine Side Effects Report #5813910-5
Clofarabine side effect was reported by a Health Professional from UNITED STATES on June 30, 2008. Male patient, 20 years of age, weighting 118.2 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, acute interstitial pneumonitis, acute respiratory distress syndrome, adenovirus infection, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, back pain
, bacterial infection . Clofarabine dosage: 68 MG, QD, INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, ACETAMINOPHEN, ACYCLOVIR, ALLOPURINOL, CEFEPIME, BENADRYL, DRONABINOL. Patient was hospitalized. Patient recovered.Clofarabine Side Effects Report #5248305-9
Clofarabine side effect was reported by a Physician from NETHERLANDS on Jan 29, 2007. Male patient, 15 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: ascites, blood amylase increased, blood bilirubin increased, conjunctival haemorrhage, conjunctivitis, convulsion, culture stool positive, dehydration, diarrhoea. Clofarabine dosage: 100 MG QD X 5 IV. During the same period patient was treated with GRANISETRON, DEXAMETHASONE, ALLOPURINOL, SDD CAPSULES, BACTRIMEL, AMPHOTERICINE, FUNGISONE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Clofarabine Side Effects Report #5538366-1
Clofarabine side effect was reported by a Health Professional from UNITED STATES on Nov 26, 2007. Female patient, 15 years of age, weighting 207.9 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: acidosis, anxiety
, ascites, bacteraemia, blood albumin decreased, blood alkaline phosphatase increased, blood amylase decreased, blood bilirubin increased, blood culture positive. Clofarabine dosage: 80 MG QD IV. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, ACETAMINOPHEN, ACYCLOVIR, ALLOPURINOL, AMIKACIN, CALCITRIOL, CHLOROTHIAZIDE. Patient died on 11/21/2007.Clofarabine Side Effects Report #4680252-3
Clofarabine side effect was reported by a Physician from on May 19, 2005. Male patient, 15 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: ascites, bacteria stool identified, blood amylase increased, blood bilirubin increased, blood creatinine increased, cerebral ischaemia, conjunctival haemorrhage, conjunctivitis, convulsion. Clofarabine dosage: 100 MG QD X 5 IV. During the same period patient was treated with GRANISETRON, DEXAMETHASONE, ALLOPURINOL, SDD CAPSULES, BACTRIMEL, AMPHOTERICINE, FUNGISONE, PARACETAMOL. Patient was hospitalized. Patient recovered.
Clofarabine Side Effects Report #4680963-X
Clofarabine side effect was reported by a Physician from on May 19, 2005. Male patient, 15 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: ascites, bacteria stool identified, blood bilirubin increased, cerebral ischaemia, conjunctival haemorrhage, conjunctivitis, convulsion, dehydration, diarrhoea. Clofarabine dosage: 100 MG QD X 5 IV. During the same period patient was treated with GRANISETRON, DEXAMETHASONE, ALLOPURINOL, SDD CAPSULES, BACTRIMEL, AMPHOTERICINE, FUNGISONE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Clofarabine Side Effects Report #5517825-1
Clofarabine side effect was reported by a Health Professional from UNITED STATES on Nov 01, 2007. Female patient, 14 years of age, weighting 125.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: abdominal discomfort, abdominal pain
, alopecia, ascites, back pain , blood magnesium decreased, caecitis, candidiasis, capillary leak syndrome. Clofarabine dosage: 63 MG QD IV. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, ACETAMINOPHEN, ACYCLOVIR, ALLOPURINOL, ALUMINUM HYDROXIDE GEL, BISACODYL, DIPHENHYDRAMINE. Patient was hospitalized. Patient recovered.Clofarabine Side Effects Report #5528013-7
Clofarabine side effect was reported by a Health Professional from UNITED STATES on Nov 09, 2007. Female patient, 14 years of age, weighting 125.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: abdominal discomfort, abdominal pain
, acute graft versus host disease in intestine, alopecia, ascites, back pain , blood albumin decreased, blood phosphorus decreased, blood phosphorus increased. Clofarabine dosage: 63 MG QD IV. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, ACETAMINOPHEN, ACYCLOVIR, ALLOPURINOL, ALUMINUM HYDROXIDE GEL, BISACODYL, DIPHENHYDRAMINE. Patient was hospitalized. Patient died on 11/18/2007.Clofarabine Side Effects Report #5518903-3
Clofarabine side effect was reported by a Health Professional from UNITED STATES on Nov 01, 2007. Female patient, 13 years of age, weighting 81.57 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, ascites, aspergillosis, bacteria stool identified, blood amylase increased, brain oedema, brain scan abnormal, capillary leak syndrome, cardio-respiratory arrest. Clofarabine dosage: 48 MG QD IV. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient recovered.
Clofarabine Side Effects Report #5216864-8
Clofarabine side effect was reported by a Physician from UNITED STATES on Jan 08, 2007. Female patient, child 11 years of age, weighting 74.96 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: abdominal abscess, abdominal pain
, abdominal tenderness, ascites, blood bilirubin increased, blood fibrinogen increased, blood potassium decreased, caecitis, cardiomegaly. Clofarabine dosage: 35 MG QD X 5 IV. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, BACTRIM, VORICONAZOLE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.Clofarabine Side Effects Report #5644403-6
Clofarabine side effect was reported by a Health Professional from UNITED STATES on Feb 21, 2008. Male patient, 70 years of age, weighting 180.8 lb, was diagnosed with acute leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: ascites, blood bilirubin increased, calcinosis, cheyne-stokes respiration, cholelithiasis, hepatomegaly, neutropenia, pancytopenia, pleural effusion. Clofarabine dosage: 35 MG, QDX5, ORAL. During the same period patient was treated with LEVAQUIN, DIFLUCAN, METFORMIN, OMEPRAZOLE, EXJADE, METOPROLOL SUCCINATE, ALPRAZOLAM, TORSEMIDE. Patient was hospitalized. Patient died on 02/19/2008.
Clofarabine Side Effects Report #5868539-X
Clofarabine side effect was reported by a Physician from UNITED STATES on Aug 20, 2008. Female patient was diagnosed with acute leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: ascites, convulsion, graft versus host disease, hepatic enzyme abnormal, hypertension, hypoxia, venoocclusive disease. Clofarabine dosage: 20 MG/M2, QDX5, INTRAVENOUS; 30 MG/M2, QDX5, INTRAVENOUS; 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with BUSULFAN, DEXAMETHASONE. Patient recovered.
Clofarabine Side Effects Report #6024231-2
Clofarabine side effect was reported by a Physician from UNITED STATES on Dec 17, 2008. Female patient was diagnosed with acute leukaemia and was treated with Clofarabine. After drug was administered, patient experienced the following side effects: ascites, convulsion, graft versus host disease, hepatic enzyme abnormal, hypertension, hypoxia, venoocclusive liver disease. Clofarabine dosage: 20 MG/M2, QDX5, INTRAVENOUS, 30 MG/M2, QDX5, INTRAVENOUS, 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with BUSULFAN, DEXAMETHASONE. Patient recovered.